IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications

Designed Enzymatic Biomaterials™ (DEB) platform debuts in laundry formulations with major consumer packaged goods launch
  • (NEW YORK=뉴스와이어)
  • 2025-09-05 13:11:27
  • 1186
  • 주소 복사
  • 밴드 공유
  • 네이버 공유
  • 카카오톡 공유
  • 페이스북 공유
  • 트위터 공유
IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com&esheet=54317958&newsitemid=20250904544995&lan=en-US&anchor=IFF&index=1&md5=6f4e9fc0d09b0ce3e1b691904d2aa7c2) (NYSE: IFF)
목록

이전글Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions

다음글바이오비쥬, 올소테크와 포괄적 기술협력을 통한 제품개발 및 유통 관련 전략적 제휴